Terms: = Germ cell tumor AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12 AND Staging
28 results:
1. The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary Thyroid Cancer.
Gild ML; Kumar S; Fuchs TL; Glover A; Sidhu S; Sywak M; Tsang V; Gill AJ; Robinson BG; Schembri G; Clifton-Bligh RJ; Hoang J
Endocr Pract; 2024 Mar; 30(3):218-224. PubMed ID: 38103829
[TBL] [Abstract] [Full Text] [Related]
2. Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature.
Zhu Z; Liu Y; Xu H; Ning H; Xia Y; Shen L
J Cardiothorac Surg; 2023 Aug; 18(1):254. PubMed ID: 37653509
[TBL] [Abstract] [Full Text] [Related]
3. Medullary thyroid carcinoma.
Pelizzo MR; Mazza EI; Mian C; Merante Boschin I
Expert Rev Anticancer Ther; 2023; 23(9):943-957. PubMed ID: 37646181
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Evolution of Sporadic Medullary Thyroid Carcinoma With Biochemical Incomplete Response After Initial Treatment.
Prete A; Gambale C; Torregrossa L; Ciampi R; Romei C; Ramone T; Agate L; Bottici V; Cappagli V; Molinaro E; Materazzi G; Elisei R; Matrone A
J Clin Endocrinol Metab; 2023 Jul; 108(8):e613-e622. PubMed ID: 36722192
[TBL] [Abstract] [Full Text] [Related]
5. Thyroidectomy Outcomes in Patients Identified With ret Pathogenic Variants Through a Population Genomic Screening Program.
Pichardo PFA; Hellums RN; Hao J; Savatt JM; Hassen D; Pellitteri PK; Alvi M; Buchanan AH; Purdy NC
JAMA Otolaryngol Head Neck Surg; 2023 Mar; 149(3):195-202. PubMed ID: 36602781
[TBL] [Abstract] [Full Text] [Related]
6. TNM staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.
Jimenez C; Ma J; Roman Gonzalez A; Varghese J; Zhang M; Perrier N; Habra MA; Graham P; Waguespack SG
J Clin Endocrinol Metab; 2023 Apr; 108(5):1132-1142. PubMed ID: 36433823
[TBL] [Abstract] [Full Text] [Related]
7. CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing.
Mancini L; Casagranda S; Gautier G; Peter P; Lopez B; Thorne L; McEvoy A; Miserocchi A; Samandouras G; Kitchen N; Brandner S; De Vita E; Torrealdea F; Rega M; Schmitt B; Liebig P; Sanverdi E; Golay X; Bisdas S
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2377-2391. PubMed ID: 35029738
[TBL] [Abstract] [Full Text] [Related]
8. The correlation between the expression of ATF4 and procalcitonin combined with the detection of
Ma S; Wang H; Li W; Yan Z; Luo X; Lu P
Can J Physiol Pharmacol; 2022 Jan; 100(1):19-25. PubMed ID: 34822305
[TBL] [Abstract] [Full Text] [Related]
9. Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer.
Chiacchiarini M; Trocchianesi S; Besharat ZM; Po A; Ferretti E
Pharmacol Ther; 2021 Mar; 219():107708. PubMed ID: 33091426
[TBL] [Abstract] [Full Text] [Related]
10. Protean cytological, histological and immunohistochemical appearances of medullary thyroid carcinoma: current updates.
Buzdugă CM; Costea CF; Cărăuleanu A; Lozneanu L; Turliuc MD; Cucu AI; Ciocoiu M; Floria M; Tănase DM; Dragomir RA; Haba RM; Dumitrescu AM; Bogdănici CM; Ciobanu Apostol DG
Rom J Morphol Embryol; 2019; 60(2):369-381. PubMed ID: 31658309
[TBL] [Abstract] [Full Text] [Related]
11. A cohort study on 10-year survival of sporadic medullary thyroid carcinoma with somatic ret mutation.
Chuang LL; Hwang DY; Tsai KB; Chan HM; Chiang FY; Hsiao PJ
Kaohsiung J Med Sci; 2016 Nov; 32(11):545-551. PubMed ID: 27847096
[TBL] [Abstract] [Full Text] [Related]
12. Management of hereditary medullary thyroid carcinoma.
Pappa T; Alevizaki M
Endocrine; 2016 Jul; 53(1):7-17. PubMed ID: 26839093
[TBL] [Abstract] [Full Text] [Related]
13. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract] [Full Text] [Related]
14. Calcium/Calmodulin-dependent protein kinase II and its endogenous inhibitor α in medullary thyroid cancer.
Russo E; Salzano M; De Falco V; Mian C; Barollo S; Secondo A; Bifulco M; Vitale M
Clin Cancer Res; 2014 Mar; 20(6):1513-20. PubMed ID: 24449826
[TBL] [Abstract] [Full Text] [Related]
15. The clinical spectrum of ret proto-oncogene mutations in codon 790.
Bihan H; Murat A; Fysekidis M; Al-Salameh A; Schwartz C; Baudin E; Thieblot P; Borson-Chazot F; Guillausseau PJ; Cardot-Bauters C; Raingeard I; Requeda E; Sadoul JL; Reznik Y;
Eur J Endocrinol; 2013 Sep; 169(3):271-6. PubMed ID: 23756355
[TBL] [Abstract] [Full Text] [Related]
16. ret proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China.
Qi XP; Chen XL; Ma JM; Du ZF; Fei J; Yang CP; Cheng J; Song QZ; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Liu WT; Zhao Y; Chen CY; Jiang HL; Ke HP; Zhang XN
Thyroid; 2012 Dec; 22(12):1257-65. PubMed ID: 23210566
[TBL] [Abstract] [Full Text] [Related]
17. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
Rischke HC; Benz MR; Wild D; Mix M; Dumont RA; Campbell D; Seufert J; Wiech T; Rössler J; Weber WA; Neumann HP
J Nucl Med; 2012 Sep; 53(9):1352-8. PubMed ID: 22836345
[TBL] [Abstract] [Full Text] [Related]
18. ⁶⁸Ga-labelled peptides in the management of neuroectodermal tumours.
Naji M; AL-Nahhas A
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S61-7. PubMed ID: 22388623
[TBL] [Abstract] [Full Text] [Related]
19. Role of prophylactic thyroidectomy in ret 790 familial medullary thyroid carcinoma.
Bihan H; Baudin E; Meas T; Leboulleux S; Al Ghuzlan A; Hannoteaux V; Travagli JP; Valleur P; Guillausseau PJ; Cohen R;
Head Neck; 2012 Apr; 34(4):493-8. PubMed ID: 21688339
[TBL] [Abstract] [Full Text] [Related]
20. Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India.
Mehrotra PK; Mishra A; Mishra SK; Agarwal G; Agarwal A; Verma AK
World J Surg; 2011 Jun; 35(6):1273-80. PubMed ID: 21479684
[TBL] [Abstract] [Full Text] [Related]
[Next]
